MX2009005783A - Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos. - Google Patents

Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.

Info

Publication number
MX2009005783A
MX2009005783A MX2009005783A MX2009005783A MX2009005783A MX 2009005783 A MX2009005783 A MX 2009005783A MX 2009005783 A MX2009005783 A MX 2009005783A MX 2009005783 A MX2009005783 A MX 2009005783A MX 2009005783 A MX2009005783 A MX 2009005783A
Authority
MX
Mexico
Prior art keywords
composition
ear
biofilm
ears
oxidase
Prior art date
Application number
MX2009005783A
Other languages
English (en)
Inventor
Michael Pellico
Original Assignee
Laclede Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laclede Inc filed Critical Laclede Inc
Publication of MX2009005783A publication Critical patent/MX2009005783A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición para remover una bio-película en los oídos es útil para el tratamiento de infecciones de oído tales como otitis media, particularmente aquellas infecciones causadas por Pseudomonas aeruginosa; en general, la composición comprende: (1) una cantidad de al menos una enzima que cataliza la hidrólisis de un enlace que conecta dos monosacáridos en un polisacárido o que conecta un monosacárido con una molécula de proteína en una glicoproteína suficiente para romper la bio-película en el oído; y (2) un portador farmacéuticamente aceptable adecuado para administración en el canal del oído; la composición además puede incluir ingredientes tales como esteroides, lisozimas, lactoferrina o una peroxidasa; si una peroxidasa está incluida, la composición puede además incluir una oxidasa para generar peróxido así como un sustrato para la oxidasa; la composición puede utilizarse en métodos para tratamiento de una infección de oídos con base en la habilidad de la composición para disolver la bio-película en el oído.
MX2009005783A 2006-12-01 2007-11-07 Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos. MX2009005783A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86813106P 2006-12-01 2006-12-01
US87032806P 2006-12-15 2006-12-15
PCT/US2007/083877 WO2008070387A1 (en) 2006-12-01 2007-11-07 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears

Publications (1)

Publication Number Publication Date
MX2009005783A true MX2009005783A (es) 2009-10-28

Family

ID=39492585

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005783A MX2009005783A (es) 2006-12-01 2007-11-07 Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.

Country Status (10)

Country Link
US (2) US20100209411A1 (es)
EP (2) EP2099466B1 (es)
JP (2) JP5762683B2 (es)
KR (2) KR20090100376A (es)
AU (1) AU2007329708B2 (es)
BR (1) BRPI0719761A2 (es)
CA (1) CA2670899C (es)
HK (1) HK1135326A1 (es)
MX (1) MX2009005783A (es)
WO (1) WO2008070387A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007123271A2 (en) * 2006-04-21 2007-11-01 Kao Corporation Composition of biofilm control agent
EP2073836A4 (en) * 2006-10-10 2010-04-07 Laclede Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES USING ENZYMES PRODUCING PEROXIDE AND PEROXIDASES
EP2099466B1 (en) * 2006-12-01 2015-06-03 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
BRPI0814412A2 (pt) * 2007-07-06 2017-05-23 Laclede Inc uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas passagens das vias aéreas
US20130004477A1 (en) * 2009-10-26 2013-01-03 Zhe Lu Methods for Treating Inflammation and Oxidative Stress Related Diseases
JP5878870B2 (ja) * 2010-09-17 2016-03-08 帝國製薬株式会社 創傷用ハイドロゲルシートの利用方法
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
EP2786658A4 (en) 2011-12-01 2015-05-20 Az Co Ltd STERILIZER, ORAL STERILIZER, STERILIZATION PROCESS AND ASSESSMENT PROCEDURE FOR A STERILIZER
WO2018005702A1 (en) * 2016-06-30 2018-01-04 Next Science, Llc Antimicrobial compositions and methods employing same
US11878050B2 (en) 2018-07-16 2024-01-23 Texas Tech University System Glycoside hydrolases to treat biofilm-associated infections
EP3603645B1 (en) * 2018-07-30 2024-08-07 Virbac Novel use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals
CN111759796B (zh) * 2019-03-15 2022-02-11 华东师范大学 一种抗生物被膜的抗生素水凝胶及其制备方法和应用
WO2022112511A1 (en) * 2020-11-26 2022-06-02 Alain Moussy Pharmaceutical composition for treatment of inner ear disorders through local administration in the tympanic area
US11672773B2 (en) 2020-12-13 2023-06-13 Next Science IP Holdings Pty Ltd Methods for treating ciliated cavities
CN114381447A (zh) * 2022-01-24 2022-04-22 哈德逊（苏州）水技术有限公司 一种胶黏物去除酶
CN115747180B (zh) * 2022-11-08 2023-09-15 青岛农业大学 一种酶组合物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340448A (en) 1978-08-28 1982-07-20 University Of Pittsburgh Potentiometric detection of hydrogen peroxide and apparatus therefor
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
JPS62249931A (ja) * 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
NL9001388A (nl) * 1990-06-19 1992-01-16 Unilever Nv Recombinant dna, cel die daarvan afgeleid dna bevat, enzym waarvoor het recombinant dna codeert en toepassingen daarvan.
WO1996031537A1 (en) * 1995-04-05 1996-10-10 The Picower Institute For Medical Research Agents for binding to advanced glycosylation endproducts, and methods of their use
AU753329C (en) 1997-06-18 2003-05-15 Montana State University Homoserine lactones biofilm regulating compounds and their methods of use
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
ES2162593B1 (es) * 2000-01-20 2002-07-01 Univ Madrid Complutense Procedimiento enzimatico para fluidificar o desprender biofilms de distintas interfases.
JP4933730B2 (ja) 2001-05-04 2012-05-16 パラテック ファーマシューティカルズ インコーポレイテッド 転写因子調節化合物およびその使用法
DK1337228T3 (da) * 2001-07-03 2006-03-20 Alcon Inc Sammensætninger til fjernelse af human cerumen
JP2003137809A (ja) * 2001-10-26 2003-05-14 Kakunai Juyotai Kenkyusho:Kk 口腔衛生用途に用いるタンパク質組成物
AU2002950862A0 (en) 2002-08-19 2002-09-12 Biosignal Pty Ltd Furanone derivatives and methods of making same
EP1558341A4 (en) 2002-11-01 2010-09-08 Paratek Pharm Innc TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
EP1621205A1 (en) 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
EP2258836B1 (en) * 2004-09-10 2016-05-04 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
CN101137359B (zh) * 2005-03-10 2011-01-12 3M创新有限公司 治疗耳感染的方法
EP2099466B1 (en) * 2006-12-01 2015-06-03 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears

Also Published As

Publication number Publication date
EP2099466A4 (en) 2012-04-11
EP2939687A1 (en) 2015-11-04
WO2008070387A1 (en) 2008-06-12
US20100209411A1 (en) 2010-08-19
US20170128547A1 (en) 2017-05-11
KR20090100376A (ko) 2009-09-23
AU2007329708A2 (en) 2009-07-30
BRPI0719761A2 (pt) 2014-01-21
AU2007329708A1 (en) 2008-06-12
JP2010511623A (ja) 2010-04-15
AU2007329708B2 (en) 2012-08-02
HK1135326A1 (en) 2010-06-04
JP5762683B2 (ja) 2015-08-12
JP2013173800A (ja) 2013-09-05
EP2099466B1 (en) 2015-06-03
KR20150041172A (ko) 2015-04-15
CA2670899C (en) 2016-11-22
EP2099466A1 (en) 2009-09-16
CA2670899A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
MX2009005783A (es) Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.
MX2010000333A (es) Uso de enzimas hidroliticas y oxidativas para disolver la biopelicula en pasajes de vias aereas.
NZ593831A (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
US8298804B2 (en) Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
NZ610068A (en) Compositions comprising povidone-iodine
NZ593823A (en) Compositions and methods for the treatment or the prevention of infections by e. coli
MA33592B1 (fr) Formulations pharmaceutiques hautement concentrées
WO2011063394A3 (en) Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
AU2003251474A1 (en) Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
EP2002841A4 (en) OPHTHALMIC COMPOSITION WITH XANTHANGUMMI AND GLUCOSE
IN2012DN05020A (es)
HUP0203402A2 (hu) Fertőzések enzimes kezelése
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
CN102119932A (zh) 硅酮水凝胶隐形眼镜用眼科组合物
WO2004052236A3 (en) Methods and compositions for treatment of otitis media
WO1999014312A1 (en) Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
MY145870A (en) Enzymes for reduced immunological stress
FR2800614A1 (fr) Composition pour le traitement des infections des voies respiratoires
HUP0103660A2 (hu) Mikróbaeredetű hialuronsavbontó enzimet tartalmazó gyógyászati készítmény
AU2003215987A1 (en) Use of hydrogen peroxide producing enzyme for treatment of otitis media
Tsao et al. Purification and characterization of three amylases from viscera of hard clam Meretrix lusoria
Singh et al. Effect of cellobiose on secretion of pectolytic and cellulolytic enzymes by blight pathogens
Shoeb et al. N-Carbamylputrescine Amidase from Pseudomonas putida ATCC 12633
WO2005063260A3 (en) Methods and compositions for the prevention of toxic side effects of aminoglycoside medications

Legal Events

Date Code Title Description
FG Grant or registration